CI: 0.34?.56; lifetime: 0.49, 95 CI: 0.38?.65) (Supplementary Figs 1 and 2, Figs S1 and S2). Prevalence by location. As for the prevalence of GAD by location, urban areas did not differ from rural areas. The current prevalence of GAD was 4.56 (95 CI: 3.45?.66) in urban and 5.51 (95 CI: 2.73?.29) in rural areas with an OR of 0.94 (95 CI: 0.61?.45) (Fig. S3). Moreover, the estimated lifetime prevalence was 4.57 (95 CI: 2.09?.06) in urban and 4.22 (95 CI: 1.76?.68) in rural areas, with an OR of 1.07 (95 CI: 0.83?.38) (Fig. S4). Non-specific anxiety disorder. Overall prevalence. The overall estimated current prevalence of NSAD was 8.30 (95 CI: 4.49?2.10) (Fig. 3), while the lifetime prevalence was a few percentage PD173074 chemical information points lower at 6.89 (95 CI: 0.43?3.35) (Fig. 2). Prevalence by gender. The current prevalence of NSAD in males was 4.01 (95 CI: 1.98?.05), while in females, it was 7.65 (95 CI: 2.96?2.34) (Table 2). A significant difference was found between males and females (OR = 0.51, 95 CI: 0.38?.67) (Fig. S1). Prevalence by location. The current prevalence of NSAD was 7.60 (95 CI: 2.19?3.01) in urban areas and 4.66 (95 CI: 1.94?.37) in rural areas (Table 2). The OR confirmed a similar rate in urban and rural areas, with a value of 1.61 (95 CI: 0.80?.24) (Fig. S3). Panic disorder. Overall prevalence. The pooled prevalence of panic disorder for current prevalence was 1.08 (95 CI: 0.74?.43) (Fig. 3), while the lifetime prevalence was 3.44 (95 CI: 2.46?.41) (Fig. 2). Prevalence by gender. The current and lifetime prevalences of panic disorder in males were 1.16 (95 CI: 0.49?.84) and 2.30 (95 CI: 1.07?.54), respectively, while in females, they were 2.01 (95 CI: 0.67?.34) and 4.53 (95 CI: 2.01?.05), respectively (Table 2). Compared with females, males seemed to have a lowerScientific RepoRts | 6:28033 | DOI: 10.1038/srepwww.nature.com/scientificreports/Mean age (SD) 43.2(17.2) ?46(15) 45(13) ?????Territorial level provincial provincial provincial city city provincial provincial provincial provincial Sampling method multistage stratified random multistage stratified random multistage stratified random multistage stratified random multistage stratified random multi-stage cluster random multi-stage cluster random multi-stage cluster random stratified, multi-stage systematic selection classification quota random cluster multi-stage stratified cluster random multi-stage stratified cluster random PPS multi-stage stratified random stratified cluster random Screening tools GHQ-12 GHQ-12 GHQ-12 GHQ-12 GHQ-12 CIDI CIDI CIDI CIDI1.0 neurosis screening table GHQ-12 CIDI1.0 Diagnostic tools SCID-I/P SCID-I/P SCID-I/P SCID-I/P SCID-I/P CIDI CIDI CIDI CIDI1.0 Diagnostic criteria Doravirine web DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV ICD-10 identity of investigator doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department psychiatrist psychiatrist psychiatrist psychiatrist psychiatrist non-psychiatric doctor doctor and nurse of psychiatry department public health doctor doctor and nurse of psychiatry department medical student psychiatrist university student psychiatrist trained researcher psychiatrist psychologist postgraduate majoring in epidemiology and statistics psychiatrist psychologist undergraduate majoring in clinic medicine doctor and nurse of psychiatry department.CI: 0.34?.56; lifetime: 0.49, 95 CI: 0.38?.65) (Supplementary Figs 1 and 2, Figs S1 and S2). Prevalence by location. As for the prevalence of GAD by location, urban areas did not differ from rural areas. The current prevalence of GAD was 4.56 (95 CI: 3.45?.66) in urban and 5.51 (95 CI: 2.73?.29) in rural areas with an OR of 0.94 (95 CI: 0.61?.45) (Fig. S3). Moreover, the estimated lifetime prevalence was 4.57 (95 CI: 2.09?.06) in urban and 4.22 (95 CI: 1.76?.68) in rural areas, with an OR of 1.07 (95 CI: 0.83?.38) (Fig. S4). Non-specific anxiety disorder. Overall prevalence. The overall estimated current prevalence of NSAD was 8.30 (95 CI: 4.49?2.10) (Fig. 3), while the lifetime prevalence was a few percentage points lower at 6.89 (95 CI: 0.43?3.35) (Fig. 2). Prevalence by gender. The current prevalence of NSAD in males was 4.01 (95 CI: 1.98?.05), while in females, it was 7.65 (95 CI: 2.96?2.34) (Table 2). A significant difference was found between males and females (OR = 0.51, 95 CI: 0.38?.67) (Fig. S1). Prevalence by location. The current prevalence of NSAD was 7.60 (95 CI: 2.19?3.01) in urban areas and 4.66 (95 CI: 1.94?.37) in rural areas (Table 2). The OR confirmed a similar rate in urban and rural areas, with a value of 1.61 (95 CI: 0.80?.24) (Fig. S3). Panic disorder. Overall prevalence. The pooled prevalence of panic disorder for current prevalence was 1.08 (95 CI: 0.74?.43) (Fig. 3), while the lifetime prevalence was 3.44 (95 CI: 2.46?.41) (Fig. 2). Prevalence by gender. The current and lifetime prevalences of panic disorder in males were 1.16 (95 CI: 0.49?.84) and 2.30 (95 CI: 1.07?.54), respectively, while in females, they were 2.01 (95 CI: 0.67?.34) and 4.53 (95 CI: 2.01?.05), respectively (Table 2). Compared with females, males seemed to have a lowerScientific RepoRts | 6:28033 | DOI: 10.1038/srepwww.nature.com/scientificreports/Mean age (SD) 43.2(17.2) ?46(15) 45(13) ?????Territorial level provincial provincial provincial city city provincial provincial provincial provincial Sampling method multistage stratified random multistage stratified random multistage stratified random multistage stratified random multistage stratified random multi-stage cluster random multi-stage cluster random multi-stage cluster random stratified, multi-stage systematic selection classification quota random cluster multi-stage stratified cluster random multi-stage stratified cluster random PPS multi-stage stratified random stratified cluster random Screening tools GHQ-12 GHQ-12 GHQ-12 GHQ-12 GHQ-12 CIDI CIDI CIDI CIDI1.0 neurosis screening table GHQ-12 CIDI1.0 Diagnostic tools SCID-I/P SCID-I/P SCID-I/P SCID-I/P SCID-I/P CIDI CIDI CIDI CIDI1.0 Diagnostic criteria DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV DSM-IV ICD-10 identity of investigator doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department doctor and nurse of psychiatry department psychiatrist psychiatrist psychiatrist psychiatrist psychiatrist non-psychiatric doctor doctor and nurse of psychiatry department public health doctor doctor and nurse of psychiatry department medical student psychiatrist university student psychiatrist trained researcher psychiatrist psychologist postgraduate majoring in epidemiology and statistics psychiatrist psychologist undergraduate majoring in clinic medicine doctor and nurse of psychiatry department.
